The Latest in the CRISPR Inventorship Battle


Robert Underwood commented that the Patent and Trademark Office hearing on who has the right to claim inventorship of the revolutionary CRISPR-Cas9 gene-editing technology focused on whether patent interference occurred in the first place, not who should be its rightful owner. “Is it possible that the patents in dispute can co-exist?” Mr. Underwood asked.